Delivery Order SPE2DR25D7062-SPE2DR26FX0CH
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,250.65 for Moxifloxacin HCL 400 mg tablets (50 unit dose packages) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, non-set-aside contract is funded through the Defense Logistics Agency's Medical Supply Chain and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is structured as a firm fixed price arrangement, typical of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Moxifloxacin 400 mg/250 mL bags. This competitively awarded, non-set-aside delivery order has a ceiling value of $1,495.80 with a firm fixed price and is scheduled for completion by July 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of Moxifloxacin Hydrochloride, a pharmaceutical product. The contract has a potential value of $6,514.78 and a completion date of February 7, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its Corporate Office division located in...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract provides for the delivery of 4,563,788,652 units of the pharmaceutical product Moxifloxacin Hydrochloride 400 mg Tablets to a location in Conshohocken, Pennsylvania. The potential value of this delivery order is $1,195.16, with a completion date of February 28, 2024....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50s. This is a firm fixed price delivery order with a ceiling value of $1,852.51 and an ultimate completion date of August 18, 2025. The award was competitively awarded with no set-aside designation, and performance will be executed from the vendor's corporate office in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. The contract, valued at $2,001.00, is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award was made through open competition without set-aside designation, and performance will be executed from AmerisourceBergen's facility in...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,345.50 contract is for the delivery of 50 units of the medication moxifloxacin hydrochloride 400 milligram tablets by March 1, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical services company Amerisourcebergen Corporation. The order, valued at $4,062.55, is for the supply of 4,564,153,041 units of the medication Moxifloxacin Hydrochloride 400 mg tablets. The delivery order has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of 4,564,763,735 units of Moxifloxacin HCl 400 mg Tablets in 50-count packages. The $8,115.12 firm fixed-price contract was awarded on May 30, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a period of performance through May 31, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,677.62 firm fixed price delivery order is for the supply of moxifloxacin hydrochloride 400 mg tablets. The award has an ultimate completion date of March 14, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA, providing a wide range of...
- SPE2DR25D7062Indefinite Delivery Contract
- SPE2DR25D7062-SPE2DR26FX0CHDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on January 23, 2026, for Moxifloxacin 400mg (30-count supply) valued at $6,513.38. The contract utilizes firm fixed-price pricing with an ultimate completion date of February 20, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. No set-aside designation was applied to this award, indicating it was competitively awarded on a full and open basis. The award supports federal military healthcare procurement as part of the DLA's pharmaceutical supply chain supporting Defense Health Agency operations and other military treatment facilities. Moxifloxacin is a fluoroquinolone antibiotic used in military and veteran healthcare applications. This delivery order exemplifies AmerisourceBergen's critical role as a prime pharmaceutical vendor for federal medical supply needs, with the company maintaining a comprehensive portfolio of drug deliveries spanning multiple therapeutic domains across its federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 1/22/26 |